EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

Development and validation of a model for stratifying haematological malignancy risk in primary care using basic blood tests

Mathilde Egelund Christensen iD, Michael Charles Sachs iD, William Grant Dunn iD, Gustav Jonzon, Margit Kriegbaum, Bent Struer Lind iD, Jan Samuelsson iD, Kirsten Groenbaek iD, George Vassiliou iD, Christen Lykkegaard Andersen iD

British Journal of Haematology · 2026-11 · 209 (5) · 2044-2055

DOI: 10.1111/bjh.70798 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift British Journal of Haematology, online erschienen am 24.09.2026. Verfasst von Mathilde Egelund Christensen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Research Unit for General Practice, Department of Public Health, University of Copenhagen, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Hematologic Neoplasms, Hematologic Tests. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kræftens Bekæmpelse, Cancer Research UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Haematological malignancies are rare in primary care and are hard to predict. Existing prediction models often require a specific working diagnosis and are based on extensive clinical information, access to which may be limited at initial work‐up in primary care. We aimed to develop a tool for estimating overall risk of haematological malignancy in primary care patients using simple data inputs. Including all full blood cell counts (FBCs) measured from 2000 to 2016 in 856 403 adult primary care patients in Eastern Denmark, we used machine learning to develop CBC‐HEMA, a risk assessment tool using FBCs, age, sex and C‐reactive protein measures to stratify ‘any haematological malignancy’ risk within 6 months, 1 year and 3 years with area under the curve (AUC) of 0.81, 0.78 and 0.71 respectively. Predictions of chronic lymphoid leukaemia and myeloproliferative disease were excellent, while CBC‐HEMA was unable to accurately predict non‐Hodgkin lymphoma and plasma cell dyscrasia. External validation was conducted in 123 015 primary care patients from Western Denmark with similar results and in 418 410 individuals from the background population cohort UK Biobank with inferior performance showing unfitness in screening healthy populations. The CBC‐HEMA https://shiny.sund.ku.dk/CopLab/blood‐cancer‐risk‐prediction/ may support risk assessment in primary care but cannot replace a clinical evaluation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematologic NeoplasmsHematologic TestsHumansFemalePrimary Health CareMaleMiddle AgedAgedRisk AssessmentAdultDenmarkMachine LearningBlood Cell Count

Stichwörter der Autor:innen

biomarkersearly detection of cancerhaematologymachine learningprimary care

Autor:innen und Institutionen

  • Research Unit for General Practice, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
  • Section of Biostatistics, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
  • Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
  • Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
  • Department of Clinical Biochemistry, Copenhagen University Hospital, Hvidovre, Denmark.
  • Department of Hematology, Linköping University Hospital, Linköping, Sweden.

ORCID-Profile: Mathilde Egelund Christensen, Michael Charles Sachs, William Grant Dunn, Bent Struer Lind, Jan Samuelsson, Kirsten Groenbaek, George Vassiliou, Christen Lykkegaard Andersen

Förderung

  • Kræftens Bekæmpelse
  • Cancer Research UK

Zitieren

APA

Christensen, M. E., Sachs, M. C., Dunn, W. G., Jonzon, G., Kriegbaum, M., Lind, B. S., Samuelsson, J., Groenbaek, K., Vassiliou, G., & Andersen, C. L. (2026). Development and validation of a model for stratifying haematological malignancy risk in primary care using basic blood tests. British Journal of Haematology, 209(5), 2044-2055. https://doi.org/10.1111/bjh.70798

Vancouver

Christensen ME, Sachs MC, Dunn WG, Jonzon G, Kriegbaum M, Lind BS, et al. Development and validation of a model for stratifying haematological malignancy risk in primary care using basic blood tests. British Journal of Haematology. 2026;209(5):2044-2055. doi:10.1111/bjh.70798

BibTeX
@article{Christensen2026,
  author = {Christensen, Mathilde Egelund and Sachs, Michael Charles and Dunn, William Grant and Jonzon, Gustav and Kriegbaum, Margit and Lind, Bent Struer and Samuelsson, Jan and Groenbaek, Kirsten and Vassiliou, George and Andersen, Christen Lykkegaard},
  title = {Development and validation of a model for stratifying haematological malignancy risk in primary care using basic blood tests},
  journal = {British Journal of Haematology},
  year = {2026},
  volume = {209},
  number = {5},
  pages = {2044--2055},
  doi = {10.1111/bjh.70798}
}
Kostenlos starten →